Edition:
United States

TapImmune Inc (TPIV.OQ)

TPIV.OQ on NASDAQ Stock Exchange Capital Market

10.13USD
16 Jul 2018
Change (% chg)

$-0.27 (-2.60%)
Prev Close
$10.40
Open
$10.37
Day's High
$10.87
Day's Low
$10.05
Volume
27,925
Avg. Vol
83,737
52-wk High
$13.54
52-wk Low
$2.60

Chart for

About

TapImmune Inc. is an immuno-oncology company. The Company specializes in the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer. The Company is engaged in developing vaccines that target candidate breast cancers, colorectal cancers, ovarian cancers and non-small cell lung cancers.... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): --
Shares Outstanding(Mil.): 10.68
Dividend: --
Yield (%): --

Financials

  TPIV.OQ Industry Sector
P/E (TTM): -- 214.97 33.20
EPS (TTM): -- -- --
ROI: -- -3.79 13.23
ROE: -- -5.32 15.28

BRIEF-Tapimmune And Marker Therapeutics Announce Entry Into Merger Agreement

* TAPIMMUNE AND MARKER THERAPEUTICS ANNOUNCE ENTRY INTO MERGER AGREEMENT, CREATING A TRANSFORMATIONAL IMMUNO-ONCOLOGY PLATFORM

May 15 2018

BRIEF-Iroquois Capital Management LLC Reports A 5.5 Pct Stake In TapImmune As Of April 4

* IROQUOIS CAPITAL MANAGEMENT LLC REPORTS A 5.5 PCT STAKE IN TAPIMMUNE AS OF APRIL 4 - SEC FILING

Apr 04 2018

Earnings vs. Estimates

No consensus analysis data available.